Amogh Kashyap
About Amogh Kashyap
Amogh Kashyap is a Research Fellow currently at the National Institutes of Health, with a background in biochemistry and molecular biology. He has gained extensive experience in clinical research and biomedical innovation through various roles, including positions at St. David's HealthCare and Cummings' Lab.
Work at National Institutes of Health
Currently, Amogh Kashyap serves as a Research Fellow at the National Institutes of Health (NIH) in Baltimore, Maryland. He has been in this role since 2020, contributing to various research initiatives. His work at NIH focuses on advancing knowledge in biomedical research, particularly in areas related to gerontology and epigenetics.
Experience in Clinical Research
Amogh Kashyap gained valuable experience in clinical research during his time as a Clinical Research Intern at St. David's HealthCare from 2018 to 2019. This nine-month position in the Austin, Texas area provided him with insights into the scientific process and clinical outcomes. Additionally, he worked as a Medical Scribe at Robin Healthcare in 2020, further enhancing his understanding of patient care and clinical documentation.
Background in Pharmacy and Healthcare
Amogh Kashyap's background includes a role as a Pharmacy Technician Trainee at Walgreens in 2016. This three-month position in Cedar Park, Texas, allowed him to develop foundational knowledge in pharmacy operations and patient interactions. His diverse experiences in healthcare settings have contributed to his comprehensive understanding of the medical field.
Education and Expertise
Amogh Kashyap completed his Bachelor of Science and Arts in Biochemistry and Molecular Biology at The University of Texas at Austin from 2016 to 2020. Prior to that, he attended McNeil High School, where he focused on Pre-Health Professions from 2012 to 2016. His educational background equips him with a solid foundation in scientific principles and research methodologies.
Research Contributions and Interests
Amogh Kashyap has contributed to research in the Translational Gerontology - Epigenetics and Stem Cell Unit at the National Institute on Aging. His interests lie in exploring innovative solutions in biomedical research, with a goal of positively impacting clinical outcomes for patients. He approaches problem-solving with a unique perspective, often questioning existing paradigms to find new avenues for research.